2024 Health Alerts
NDHAN: Health Advisory: Clade I Mpox Identified in the United States
NDHAN Health Advisory: NDHHS recommends clinicians to maintain awareness for Marburg Virus Disease (MVD) in patients who have recently been in Rwanda and present with signs and symptoms consistent with the illness
NDHAN: Health Advisory: Health Care Providers Are Reminded to Consider Measles
NDHAN: Health Advisory: Pertussis Cases Are Increasing in North Dakota
NDHAN: Health Advisory: Recommendations for Respiratory Infection Season
NDHAN: Health Advisory: Increase Oropouche Virus Activity and Associated Risk to Travelers
NDHAN: Health Advisory: Increase in Human Parvovirus B19 Activity in the Unitd States
NDHAN: Health Advisory: North Dakota recommends clinicians and jurisdictions in the United States maintain a heightened index of suspicion for mpox in patients who have recently been in Democratic Republic of Congo (DRC) or to any country sharing a border with and presenting with signs and symptoms consistent with mpox.
NDHAN: Health Advisory: First Confirmed Case of Candida auris Reported in North Dakota
NDHAN: Health Advisory: Disruptions in Availability of Becton Dickinson (BD) BACTEC Blood Culter Bottles
NDHAN: Health Advisory: Increased Risk of Dengue Virus Infections in the United States
NDHAN: Health Advisory: Severe Acute Illness potentially associated with consuming Diamond Shruumz brand chocolate bars, cones, and gummies.
NDHAN: Adverse Effects Linked to Counterfeit or Mishandled Botulinum Toxin Injections in the United States
NDHAN: Health Advisory: Highly Pathogenic Avian Influenza Update
NDHAN: Health Advisory: Due to an Increase in Invasive Serogroup Y Meningococcal Disease, North Dakota Providers are Encouraged to have a Heightened Awareness of Meningococcal Disease and Ensure Patients are Up to Date for Meningococcal Vaccines
NDHAN: Health Advisory: ND Providers are Encouraged to Make Sure Patients are Up-to-Date on Measles Vaccine, Recommend Vaccinations for International Travelers Six Months and Older
NDHAN: Health Advisory Confirmed Hepatitis A Case in North Dakota
NDHAN: Health Advisory: No to Low-Cost COVID-19 Treatment Available
NDHAN: Health Advisory: Importation of Benzathine Benzylpenicillin to Help Address Bicillin L-A Shortage
2023 Health Alerts
NDHAN: Health Advisory: North Dakota Providers Should be Aware of Recent Reports of Human-to-Human Spread of Clade I Mpox in the DRC
NDHAN: Health Advisory: Severe and Fatal Confirmed Rocky Mountain Spotted Fever among People with Recent Travel to Tecate, Mexico
ND HAN: Health Advisory: High Blood Lead Levels in Children from Recalled Applesauce
NDHAN: Health Advisory North Dakota Experiencing an Increase in Pertussis Cases
NDHAN: Health Advisory Limited Availability of Nirsevimab in the United States - Interim CDC Recommendations to Protect Infants from Respiratory Syncytial Virus (RSV) during the 2023 - 2024 Respiratory Virus Season
NDHAN: Health Advisory Limited Availability of Nirsevimab in the United States -- Interim CDC Recommendations to Protect Infants from Respiratory Syncytial Virus (RSV) during the 2023 - 2024 Respiratory Virus Season
NDHAN: Current Shortage of Bicillin L-A and Syphilis Treatment Recommendations
NDHAN: Health Advisory Recommendations for Respiratory Infection Season
NDHAN: Health Advisory Health Care Providers Urged to Maintain Awareness for Mpox as New Cases are Identified in Illinois
NDHAN: Health Update: COVID-19 Public Health Emergency Ended
NDHAN: Cyber Awareness in Medical Facilities Lifeseize Meeting, May 2, 2023
NDHAN: Potential Access Challenges to Bicillin L-A
NDHAN: Health Advisory Marburg Virus Disease Outbreak Information
Download (PDF)
NDHAN: Health Advisory National Shortage of Rifampin Capsules
NDHAN: Health Advisory Possible Measles Exposure Associated with Travel to Kentucky and Abroad
NDHAN: Health Advisory Increased Chikungunya Virus Activity in Paraguay and Associated Risk to Travelers
NDHAN: Health Advisory Drug-Resistant Shigella Infections (Shigellosis) in he United States
NDHAN: Health Advisory Evusheld is not currently authorized for use
2022 Health Alerts
NDHAN: Health Advisory Oseltamivir Availability and Treatment Priorities
NDHA: Health Advisory Bebtelovimab is no longer authorized for use
NDHAN: Health Advisory Ebola Virus Disease Update
NDHAN: Health Advisory Respiratory Virus Activity
NDHAN: Health Advisory Nontuberculous Mycobacteria Infections - Dental Water Source
NDHAN: Health Advisory Monkeypox Severity Among the Immunocompromised
NDHAN Update on COVID-19 therapeutics (8/8/2022)
NDHAN Monkeypox Management in Certain Patient Populations
NDHAN: Health Advisory Human Parechovirus (PeV) Infections in Neonates and Young Infants
NDHAN: Health Advisory Syphilis on the Rise
NDHAN: Monkeypox Update for Providers
NDHAN: COVID-19 Rebound after Paxlovid treatment
NDHAN: Monkeypox in the United States and Other Countries
NDHAN Update: Guidance for Adenovirus Testing and Typing of Patients Under Investigation - Pediatric Acute Hepatitis of Unknown Etiology
NDHAN Detection of HPAI H5N1 in Colorado Patient
NDHAN: Health Advisory Call for Case Reports - Pediatric Acute Hepatitis of Unknown Etiology
NDHAN: Testing, treatment and infection control recommendations for providers managing patients with confirmed or suspected avian influenza
NDHAN: Health Advisory Update to COVID-19 laboratory reporting requirements to public health: Effective April 4, 2022.
NDHAN: Health Advisory Update on Evusheld
NDHAN: Health Advisory Abbott Recalls Infant Formulas Concerning Infections with Cronobacter sp. and Salmonella sp.
NDHAN: Health Advisory HSS UPdate on COVID-19 therapeutics
NDHAN: Health Advisory FDA Approves First Injectable Treatment for Pre-Exposure Prophylaxis (PrEP)
NDHAN: Health Advisory Update: Omicron Variant Update
Download alert (pdf)
Download COVID-19 Outpatient Therapeutics Decision Guide (pdf)
NDHAN: Health Advisory Update: Omicron and COVID-19 Therapies